Human cells assembling into fractal-like clusters

Tree-like branching structures are everywhere in the human body, from the bronchial system in the lungs to the spidering capillaries that supply blood to the extremities. Researchers have long worked to understand the cellular signaling needed to build these intricate structures, but new research suggests that simple physics may play an underappreciated role. The research, published in the Proceedings of […]

Read more

Better tools, better cancer immunotherapy

In the journal Science Immunology, researchers from DTU Health Technology and Jacobs University in Bremen have just published their cutting-edge research demonstrating advancement in detection of a certain type of immune cells, called T cells. Improved detection of T cells have several therapeutic implications. For example, in cancer immunotherapy (a therapeutic approach that engage patients own immune cells) characterization of […]

Read more

Study links progenitor cells to age-related prostate growth: As the organ enlarges, the risk for cancer and other diseases increases

The prostates of older mice contain more luminal progenitor cells — cells capable of generating new prostate tissue — than the prostates of younger mice, UCLA researchers have discovered. The observation, published in Cell Reports, helps explain why, as people age, the prostate tends to grow, leading to an increased risk for prostate cancer and other conditions. “Understanding what’s causing […]

Read more

Researchers unlock cancer cells’ feeding mechanism, central to tumor growth: The findings could lead to new treatments by blocking tumor growth at its roots

An international team led by researchers from the University of Cincinnati and Japan’s Keio and Hiroshima universities has discovered the energy production mechanism of cancerous cells that drives the growth of the nucleolus and causes tumors to rapidly multiply. The findings, published Aug. 1 in the journal Nature Cell Biology, could lead to the development of new cancer treatments that […]

Read more

Evidence a cancer drug may be extended to many more patients

A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating all cancers where the drugs are used, including ovarian and prostate cancers. The new study also revealed a potential biomarker indicating when these drugs, called PARP inhibitors, can be unleashed […]

Read more

‘Can you hear me, now?’ A new strategy ‘raises the volume’ of gut-body communication

Throughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells and, although they comprise only a small population of the total cells, they are one of the most important moderators of communication between the gut and the rest of the body. Studying these cells, however, has been difficult. “Enteroendocrine cells are extremely challenging to study because we just […]

Read more

Cascade exacerbates storage diseases: Researchers show that a defective degradation enzyme triggers a series of consequential damages

In rare, hereditary storage diseases such as Sandhoff’s disease or Tay-Sachs syndrome, the metabolic waste from accumulating gangliosides cannot be properly disposed of in the nerve cells because important enzymes are missing. The consequences for the patients are grave: They range from movement restrictions to blindness, mental decline and early death. Scientists at the University of Bonn now demonstrate why […]

Read more

Terminal cancer patient’s new treatment ‘has his lymphoma on the run’

Cancer patient, 62, told his lymphoma was terminal claims the disease is now ‘on the run’ after being given pioneering ‘living drug’ treatment Mike Simpson was told he may have only two unpleasant years left to live But gruelling new cancer treatment has restored his hopes of beating the illness Experts say the therapy is having ‘incredibly impressive’ results in […]

Read more

A treasure map to understanding the epigenetic causes of disease

More than 15 years after scientists first mapped the human genome, most diseases still cannot be predicted based on one’s genes, leading researchers to explore epigenetic causes of disease. But the study of epigenetics cannot be approached the same way as genetics, so progress has been slow. Now, researchers at the USDA/ARS Children’s Nutrition Research Center at Baylor College of […]

Read more

Immunotherapy drug found safe in treating cancer patients with HIV, study suggests: Researchers seek to break down HIV exclusions in cancer clinical trials

The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®. During an ASCO presentation concurrent with release of a study in JAMA Oncology, Fred Hutch […]

Read more
1 2 3 4